To investigate the role of EYA1-BCL2L12 signaling pathway in glioma development, we initially knocked down endogenous EYA1 in the glioma cell lines T98G, U87MG, and U251MG using siRNAs. This evidence concerns the gene BCL2L12 and central nervous system cancer.